Lista de obras -

Chemotherapy for teratoma with malignant transformation

artículo científico publicado en 2003

Clinical Outcomes of Local and Metastatic Testicular Sex Cord-Stromal Tumors

artículo científico publicado en 2014

Clinical impact of residual extraretroperitoneal masses in patients with advanced nonseminomatous germ cell testicular cancer

artículo científico publicado en 2012

Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour

artículo científico publicado en 2007

Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors

artículo científico publicado en 2005

Contemporary lymph node counts during primary retroperitoneal lymph node dissection.

artículo científico publicado en 2010

Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumors

artículo científico publicado en 2005

Evaluation of lymph node counts in primary retroperitoneal lymph node dissection.

artículo científico publicado en 2010

Improved Clinical Outcome in Recent Years for Men With Metastatic Nonseminomatous Germ Cell Tumors

article

Incidence and Clinical Outcome of Patients with Teratoma in the Retroperitoneum Following Primary Retroperitoneal Lymph Node Dissection for Clinical Stages I and IIA Nonseminomatous Germ Cell Tumors

artículo científico publicado en 2003

Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer.

artículo científico publicado en 2007

Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy

artículo científico publicado en 2005

Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.

artículo científico publicado en 2007

Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma

artículo científico publicado en 2007

Medical treatment of advanced testicular cancer.

artículo científico publicado en 2008

Nonrandomized Comparison of Primary Chemotherapy and Retroperitoneal Lymph Node Dissection for Clinical Stage IIA and IIB Nonseminomatous Germ Cell Testicular Cancer

artículo científico publicado en 2007

Outcomes After Resection of Postchemotherapy Residual Neck Mass in Patients With Germ Cell Tumors—An Update

artículo científico publicado en 2011

Outcomes in patients with clinical stage III NSGCT who achieve complete clinical response to chemotherapy at extraretroperitoneal disease site.

artículo científico

Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin Plus Etoposide in Previously Treated Germ Cell Tumors

artículo científico publicado en 2007

Phase I/II Trial of Paclitaxel With Ifosfamide Followed by High-Dose Paclitaxel, Ifosfamide, and Carboplatin (TI-TIC) With Autologous Stem Cell Reinfusion for Salvage Treatment of Germ Cell Tumors.

artículo científico publicado en 2015

Phase II Trial of ixabepilone in patients with cisplatin-refractory germ cell tumors

artículo científico publicado en 2007

Phase II trial of temozolomide in patients with cisplatin-refractory germ cell tumors

artículo científico publicado en 2004

Predicting Teratoma in the Retroperitoneum in Men Undergoing Post-Chemotherapy Retroperitoneal Lymph Node Dissection

article

Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: endpoints for clinical trial design.

artículo científico publicado en 2011

RETROPERITONEAL LYMPH NODE DISSECTION IN PATIENTS WITH LOW STAGE TESTICULAR CANCER WITH EMBRYONAL CARCINOMA PREDOMINANCE AND/OR LYMPHOVASCULAR INVASION

scientific article published on 01 August 2005

Rates of teratoma and viable cancer at post-chemotherapy retroperitoneal lymph node dissection after induction chemotherapy for good risk nonseminomatous germ cell tumors.

artículo científico publicado en 2014

Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy

artículo científico publicado en 2004

Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: clinical presentation, patterns of recurrence, and outcome

articulo cientifico

Results of Retroperitoneal Lymph Node Dissection for Clinical Stage I and II Pure Embryonal Carcinoma of the Testis

artículo científico publicado en 2003

Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer: Impact of Patient Selection Factors on Outcome

artículo científico publicado en 2005

Salvage chemotherapy for patients with advanced pure seminoma

artículo científico publicado en 2002

The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor

artículo científico publicado en 2008

Lista de obras de

Chemotherapy for teratoma with malignant transformation

Clinical Outcomes of Local and Metastatic Testicular Sex Cord-Stromal Tumors

Clinical impact of residual extraretroperitoneal masses in patients with advanced nonseminomatous germ cell testicular cancer

Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour

Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors

Contemporary lymph node counts during primary retroperitoneal lymph node dissection.

Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumors

Evaluation of lymph node counts in primary retroperitoneal lymph node dissection.

Improved Clinical Outcome in Recent Years for Men With Metastatic Nonseminomatous Germ Cell Tumors

Incidence and Clinical Outcome of Patients with Teratoma in the Retroperitoneum Following Primary Retroperitoneal Lymph Node Dissection for Clinical Stages I and IIA Nonseminomatous Germ Cell Tumors

Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer.

Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy

Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.

Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma

Medical treatment of advanced testicular cancer.

Nonrandomized Comparison of Primary Chemotherapy and Retroperitoneal Lymph Node Dissection for Clinical Stage IIA and IIB Nonseminomatous Germ Cell Testicular Cancer

Outcomes After Resection of Postchemotherapy Residual Neck Mass in Patients With Germ Cell Tumors—An Update

Outcomes in patients with clinical stage III NSGCT who achieve complete clinical response to chemotherapy at extraretroperitoneal disease site.

Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin Plus Etoposide in Previously Treated Germ Cell Tumors

Phase I/II Trial of Paclitaxel With Ifosfamide Followed by High-Dose Paclitaxel, Ifosfamide, and Carboplatin (TI-TIC) With Autologous Stem Cell Reinfusion for Salvage Treatment of Germ Cell Tumors.

Phase II Trial of ixabepilone in patients with cisplatin-refractory germ cell tumors

Phase II trial of temozolomide in patients with cisplatin-refractory germ cell tumors

Predicting Teratoma in the Retroperitoneum in Men Undergoing Post-Chemotherapy Retroperitoneal Lymph Node Dissection

Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: endpoints for clinical trial design.

RETROPERITONEAL LYMPH NODE DISSECTION IN PATIENTS WITH LOW STAGE TESTICULAR CANCER WITH EMBRYONAL CARCINOMA PREDOMINANCE AND/OR LYMPHOVASCULAR INVASION

Rates of teratoma and viable cancer at post-chemotherapy retroperitoneal lymph node dissection after induction chemotherapy for good risk nonseminomatous germ cell tumors.

Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy

Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: clinical presentation, patterns of recurrence, and outcome

Results of Retroperitoneal Lymph Node Dissection for Clinical Stage I and II Pure Embryonal Carcinoma of the Testis

Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Testicular Cancer: Impact of Patient Selection Factors on Outcome

Salvage chemotherapy for patients with advanced pure seminoma

The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor